EVALUATION OF CIRCULATING TUMOUR CELLS (CTCS) IN SMALL CELL LUNG CANCER (SCLC) PATIENTS UNDERGOING CHEMOTHERAPY

被引：0
|
作者：
Hou, J. [1 ]
Greystoke, A. [1 ]
Williamson, A. [2 ]
Lancashire, L. [2 ]
Ashcroft, L. F. [3 ]
Lorigan, P. [4 ]
Hughes, S. [2 ]
Dive, C. [1 ]
Blackhall, F. H. [4 ]
机构：
[1] Paterson Inst Canc Res, Manchester M20 9BX, Lancs, England
[2] PICR, Cep, Manchester, Lancs, England
[3] Christie Hosp, Dept Biostat, Manchester, Lancs, England
[4] Christie Hosp, Dept Med Oncol, Manchester, Lancs, England
来源：
ANNALS OF ONCOLOGY | 2008年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：252 / 252
页数：1
相关论文
共 50 条
  • [1] Heterogeneity of circulating tumor cells (CTCs) in patients with recurrent small cell lung cancer (SCLC) treated with pazopanib
    Messaritakis, I.
    Politaki, E.
    Plataki, M.
    Karavassilis, V.
    Kentepozidis, N.
    Koinis, F.
    Samantas, E.
    Georgoulias, V.
    Kotsakis, A.
    LUNG CANCER, 2017, 104 : 16 - 23
  • [2] Evaluation of Circulating Tumor Cells and Serological Cell Death Biomarkers in Small Cell Lung Cancer Patients Undergoing Chemotherapy
    Hou, Jian-Mei
    Greystoke, Alastair
    Lancashire, Lee
    Cummings, Jeff
    Ward, Tim
    Board, Ruth
    Amir, Eitan
    Hughes, Sarah
    Krebs, Matthew
    Hughes, Andrew
    Ranson, Malcolm
    Lorigan, Paul
    Dive, Caroline
    Blackhall, Fiona H.
    AMERICAN JOURNAL OF PATHOLOGY, 2009, 175 (02): : 808 - 816
  • [3] MEASUREMENT OF CIRCULATING TUMOR CELLS (CTCS) IN PATIENTS WITH SMALL CELL LUNG CANCER (SCLC) DURING A PHASE II CLINICAL TRIAL
    Pietanza, Maria Catherine
    Krug, Lee M.
    Sima, Camelia S.
    Bergagnini, Isabella
    Sumner, Dyana K.
    Kris, Mark G.
    Fleisher, Martin
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S646 - S647
  • [4] Quantifying EpCAM heterogeneity of circulating-tumor-cells (CTCs) from small cell lung cancer (SCLC) patients.
    Sorotsky, Hadas
    Aparanthi, Mansi
    Wang, Daniel Zongjie
    McFadden, Francesca
    Popescu, Sandra N.
    Mohamadi, Reza M.
    Pereira, Mark
    Weiss, Jessica
    Patel, Devalben
    Majeed, Safa
    Cabanero, Michael
    Sacher, Adrian G.
    Bradbury, Penelope Ann
    Leighl, Natasha B.
    Shepherd, Frances A.
    Tsao, Ming Sound
    Liu, Geoffrey
    Kelley, Shana O.
    Lok, Benjamin H.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [5] Reduction of the risk of transfusion in patients with small cell lung cancer (SCLC) undergoing chemotherapy
    Thatcher, N
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 234 - 234
  • [6] Circulating tumor cells as a predictive biomarker in patients with small cell lung cancer undergoing chemotherapy
    Aggarwal, Charu
    Wang, Xingmei
    Ranganathan, Anjana
    Torigian, Drew
    Troxel, Andrea
    Evans, Tracey
    Cohen, Roger B.
    Vaidya, Bhavesh
    Rao, Chandra
    Connelly, Mark
    Vachani, Anil
    Langer, Corey
    Albelda, Steven
    LUNG CANCER, 2017, 112 : 118 - 125
  • [7] Integrative analysis of circulating tumor cells (CTCs) and exosomes from small-cell lung cancer (SCLC) patients: a comprehensive approach
    Papakonstantinou, Dimitrios
    Roumeliotou, Argyro
    Pantazaka, Evangelia
    Shaukat, Athanasios-Nasir
    Christopoulou, Athina
    Koutras, Angelos
    Dimitrakopoulos, Foteinos-Ioannis
    Georgoulias, Vassilis
    Xagara, Anastasia
    Chantzara, Evangelia
    Koinis, Fillipos
    Kotsakis, Athanasios
    Stathopoulos, Constantinos
    Kallergi, Galatea
    MOLECULAR ONCOLOGY, 2024,
  • [8] Circulating tumour cells from small cell lung cancer patients are tumourigenic
    Hodgkinson, C.
    Morrow, C.
    Tugwood, J.
    Li, Y.
    Metcalf, R.
    Rothwell, D.
    Trapani, F.
    Burt, D.
    Simpson, K.
    Morris, K.
    Pepper, S.
    Nonake, D.
    Greystoke, A.
    Kelly, P.
    Bola, B.
    Polanski, R.
    Krebs, M.
    Antonello, J.
    Ayub, M.
    Faulkner, S.
    Priest, L.
    Carter, L.
    Tate, C.
    Miller, C.
    Blackhall, F.
    Brady, G.
    Dive, C.
    LUNG CANCER, 2015, 87 : S1 - S1
  • [9] The clinical utility of circulating tumour cells in patients with small cell lung cancer
    Foy, Victoria
    Fernandez-Gutierrez, Fabiola
    Faivre-Finn, Corinne
    Dive, Caroline
    Blackhall, Fiona
    TRANSLATIONAL LUNG CANCER RESEARCH, 2017, 6 (04) : 409 - 417
  • [10] Assessment of PD-L1 expression on circulating tumor cells (CTCs) and immune cells in peripheral blood of patients with small cell lung cancer (SCLC)
    Papadaki, M. A.
    Kapetanaki, E-E.
    Vorrias, E.
    Mavroudis, D.
    Agelaki, S.
    ANNALS OF ONCOLOGY, 2021, 32 : S1166 - S1166
12345